Charles Schwab Investment Management Inc Talaris Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	SELL	$1.78 - $3.2 $65,471 - $117,702	-36,782 Reduced 72.85%	13,707 $41,000
Q4 2022 Feb 13, 2023	SELL	$0.94 - $1.64 $3,326 - $5,803	-3,539 Reduced 6.55%	50,489 $51,000
Q2 2022 Aug 15, 2022	BUY	$4.51 - $9.85 $8,884 - $19,404	1,970 Added 3.78%	54,028 $244,000
Q1 2022 May 13, 2022	BUY	$6.89 - $16.56 $16,205 - $38,949	2,352 Added 4.73%	52,058 $513,000
Q4 2021 Feb 11, 2022	BUY	$12.18 - $17.0 $332,465 - $464,032	27,296 Added 121.8%	49,706 $761,000
Q2 2021 Aug 16, 2021	BUY	$12.25 - $18.61 $274,522 - $417,050	22,410 New	22,410 $330,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.